Ventyx Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Ventyx Biosciences
VTYX Stock  USD 10.05  2.23  28.52%   
Ventyx Biosciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Ventyx Biosciences' valuation are provided below:
Market Capitalization
558 M
Earnings Share
(1.49)
We have found one hundred twenty available fundamental trend indicators for Ventyx Biosciences, which can be analyzed and compared to other ratios and to its competition. All investors should make sure to double-check all of Ventyx Biosciences current market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 163.8 M in 2026. Enterprise Value is likely to drop to about 145.9 M in 2026
Check Ventyx Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ventyx Biosciences' main balance sheet or income statement drivers, such as Net Interest Income of 16.2 M, Depreciation And Amortization of 1.9 M or Interest Expense of 5.7 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.56. Ventyx financial statements analysis is a perfect complement when working with Ventyx Biosciences Valuation or Volatility modules.
  
Build AI portfolio with Ventyx Stock
Check out the analysis of Ventyx Biosciences Correlation against competitors.
For more information on how to buy Ventyx Stock please use our How to Invest in Ventyx Biosciences guide.

Ventyx Biosciences Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets223.3 M318 M103.7 M
Slightly volatile
Short and Long Term Debt Total9.1 M12.4 M5.8 M
Slightly volatile
Other Current Liabilities7.7 M9.9 M3.6 M
Slightly volatile
Total Current Liabilities12 M14.7 M5.8 M
Slightly volatile
Accounts Payable3.9 M3.6 M1.9 M
Slightly volatile
Cash39.4 M31.3 M17 M
Slightly volatile
Long Term Debt9.1 M14.5 M7.4 M
Slightly volatile
Cash And Short Term Investments191.9 M249.9 M87.7 M
Slightly volatile
Common Stock Shares Outstanding51.7 M78.7 M25.3 M
Slightly volatile
Liabilities And Stockholders Equity223.3 M318 M103.7 M
Slightly volatile
Non Current Liabilities Total8.1 M8.8 M6.6 M
Slightly volatile
Other Current Assets7.5 M13 M3.6 M
Slightly volatile
Other Stockholder Equity975.9 M929.4 M256.4 M
Slightly volatile
Total Liabilities22.3 M25.9 M12.3 M
Slightly volatile
Total Current Assets199.5 M264.1 M91.5 M
Slightly volatile
Other Liabilities13.5 M15.2 M16.6 M
Slightly volatile
Non Currrent Assets Other623.4 K1.2 M278.8 K
Slightly volatile
Net Receivables1.2 M1.1 M292.6 K
Slightly volatile
Common Stock Total Equity6 K6.9 K5.3 K
Slightly volatile
Capital Surpluse538.1 M668.4 M453.8 M
Slightly volatile
Common Stock6.6 K8.1 K5.5 K
Slightly volatile
Property Plant Equipment363.6 K468.1 K300 K
Slightly volatile
Short Term Debt903.8 K1.2 M560.2 K
Slightly volatile

Ventyx Biosciences Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.9 M1.2 M3.2 M
Slightly volatile
Interest Expense5.7 M5.4 M1.6 M
Slightly volatile
Selling General Administrative18.2 M36.2 M9.4 M
Slightly volatile
Other Operating Expenses100.5 M170.7 M50.4 M
Slightly volatile
Research Development82.3 M134.6 M41 M
Slightly volatile
Total Operating Expenses100.5 M170.7 M50.4 M
Slightly volatile
Interest Income9 M15.4 M3.4 M
Slightly volatile
Preferred Stock And Other Adjustments1.2 M1.4 M1.5 M
Slightly volatile
Cost Of Revenue1.6 M1.6 M370.4 K
Slightly volatile
Selling And Marketing Expenses0.80.90.9824
Slightly volatile

Ventyx Biosciences Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation27.7 M26.4 M7.5 M
Slightly volatile
Other Cashflows From Financing Activities26.5 M24.4 M14.7 M
Slightly volatile
Depreciation1.6 M1.6 M370.4 K
Slightly volatile
Capital Expenditures332.9 K277.1 K281.4 K
Slightly volatile
Total Cash From Financing Activities123.9 M140.4 M56.9 M
Slightly volatile
End Period Cash Flow39.8 M32.5 M17.2 M
Slightly volatile
Change To Netincome22 M19.1 M9.6 M
Slightly volatile
Change To Liabilities4.2 M4 M1.5 M
Slightly volatile
Sale Purchase Of Stock213.8 K225 K228.1 M
Slightly volatile
Exchange Rate Changes8.8 K9.9 K10.8 K
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Capex To Depreciation0.20.216.2659
Slightly volatile
Payables Turnover0.410.390.0908
Slightly volatile
Cash Per Share2.512.861.5073
Slightly volatile
Days Payables Outstanding92697540.6 K
Slightly volatile
Income Quality0.540.870.6435
Slightly volatile
Net Debt To EBITDA0.130.140.8132
Slightly volatile
Current Ratio9.6216.186.0576
Slightly volatile
Capex Per Share0.00630.0040.0053
Very volatile
Interest Debt Per Share0.170.181.2594
Slightly volatile
Debt To Assets0.04260.04499.5295
Slightly volatile
Days Of Payables Outstanding92697540.6 K
Slightly volatile
Ebt Per Ebit1.661.051.2413
Pretty Stable
Effective Tax Rate0.00350.00390.0043
Slightly volatile
Quick Ratio9.6216.186.0576
Slightly volatile
Net Income Per E B T1.111.151.0339
Pretty Stable
Cash Ratio1.981.921.3616
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.11.151.0199
Slightly volatile
Debt Ratio0.04260.04499.5295
Slightly volatile

Ventyx Biosciences Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap163.8 M172.5 M881.6 M
Slightly volatile
Enterprise Value145.9 M153.5 M877.6 M
Slightly volatile

Ventyx Fundamental Market Drivers

Ventyx Upcoming Events

28th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Ventyx Biosciences Financial Statements

Ventyx Biosciences investors use historical fundamental indicators, such as Ventyx Biosciences' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Ventyx Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue1.6 M1.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
JBLJabil Circuit
MRKMerck Company
AMGNAmgen Inc

Additional Tools for Ventyx Stock Analysis

When running Ventyx Biosciences' price analysis, check to measure Ventyx Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ventyx Biosciences is operating at the current time. Most of Ventyx Biosciences' value examination focuses on studying past and present price action to predict the probability of Ventyx Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ventyx Biosciences' price. Additionally, you may evaluate how the addition of Ventyx Biosciences to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY